On the other hand, CLL-1 expression was significantly higher (17-fold) in AML FAB M5 patients, indicating a poor prognosis, and patients with AML FAB M4 and M2 expression showed a moderate increase (2.7- and 3.5-fold, respectively). The gene discussed is CLEC12A; the disease is acute myeloid leukemia.